Neurophenotype Predicts CD Disease Progression

Status Recruiting

Clinical Trial Summary

The goal of this observational study is aimed to develop a novel multimodal neuroimaging-based model to characterize the neurophenotype of Crohn's Disease patients and assess its ability for predicting disease progression, using multiomics data to interpret the model. Participants will be followed-up of at least six months for patients without disease progression to assess the relationship between neurophenotype and intestinal outcomes.

Clinical Trial Description

Brain-gut axis plays a crucial role in the pathogenesis of Crohn's disease (CD); however, CD neurophenotype and its impact on intestinal disease progression remain unclear. We aimed to develop a novel multimodal neuroimaging-based model to characterize the neurophenotype of CD patients and assess its ability for predicting disease progression, using multiomics data to interpret the model. This study enrolled CD patients who underwent baseline testing (including neuroimaging, psychological scales, MR enterography, and ileocolonoscopy) and faecal/blood samples collection. The neurophenotypes of patients were characterized using a neuroimaging-based model. The predictive ability of neurophenotype model for disease progression was evaluated using Cox regression analysis. Multiomics data (including faecal microbiome, faecal/blood metabolomics, intestinal permeability, blood-brain-barrier permeability, and blood neurotransmitter levels) were used to elucidate how neurophenotypes reflect brain-gut interactions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06452550
Study type	Observational
Source	First Affiliated Hospital, Sun Yat-Sen University
Contact	Xuehua Li
Phone	13580364103
Email	lxueh@mail.sysu.edu.cn
Status	Recruiting
Phase
Start date	May 1, 2021
Completion date	June 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05517889` - Repeatability and Stability of Healthy Skin Features on OCT
Recruiting	`NCT04553601` - Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer	N/A
Recruiting	`NCT05736991` - Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma
Completed	`NCT06381895` - The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer
Recruiting	`NCT04003558` - Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
Recruiting	`NCT04004559` - MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
Not yet recruiting	`NCT05761912` - Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy
Recruiting	`NCT04792437` - Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data
Not yet recruiting	`NCT05369689` - Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics
Active, not recruiting	`NCT05889949` - Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
Completed	`NCT05784207` - An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors
Recruiting	`NCT03592004` - Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer
Active, not recruiting	`NCT06062173` - Preoperative Prediction of Adherent Perirenal Fat.
Recruiting	`NCT05174208` - Study of Imaginomics Predicting Early Surgical Rates in Crohn's Disease
Recruiting	`NCT04483804` - Application of Radiomics in Breast Cancer
Recruiting	`NCT03871140` - Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis
Completed	`NCT06167863` - Retrospective Analysis of the Correlation Between Imaging Features and Pathology, Prognosis in Renal Tumors